Ablate and pace: Is there still a role?

Alexandru Bogdan Chicos*, Bradley Paul Knight

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Despite the development of newer drugs and procedures to improve rhythm control, there is still a place for ablation of the atrioventricular junction (AVJ) in the management of selected patients with AF who are refractory to medical therapy, to improve quality of life, prevent ventricular dysfunction, and to optimize cardiac resynchronization therapy. We review all aspects of the "ablate and pace" strategy, from its history to patient selection, technique, outcomes and applications, and identify the need for randomized clinical trials to address some of the remaining questions regarding its application in some groups of patients.

Original languageEnglish (US)
Pages (from-to)403-412
Number of pages10
JournalCardiac Electrophysiology Clinics
Issue number3
StatePublished - Sep 1 2012


  • Ablate and pace
  • Ablation
  • Atrioventricular junction
  • Atrioventricular node

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Ablate and pace: Is there still a role?'. Together they form a unique fingerprint.

Cite this